ICON plc - Ordinary Shares (ICLR)
195.01
+0.00 (0.00%)
NASDAQ · Last Trade: Jul 25th, 9:35 AM EDT
ICON lifts its 2025 revenue forecast, beats booking targets in Q2 and expands its share buyback plan as market conditions remain variable.
Via Benzinga · July 24, 2025
Via Benzinga · July 24, 2025
Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via Chartmill · July 24, 2025

When you look at ICON PLC (NASDAQ:ICLR), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
Via Chartmill · January 27, 2025
Via Benzinga · July 24, 2025
Via Benzinga · July 24, 2025
ICON PLC (ICLR) reported Q2 2025 earnings slightly below estimates but saw a 13.76% stock surge. Revenue hit $2.02B, EPS $3.26. AGM resolutions passed, boosting investor confidence.
Via Chartmill · July 23, 2025
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · July 23, 2025
Via Benzinga · July 22, 2025
ICON PLC (NASDAQ:ICLR) appears undervalued with strong profitability and reasonable financial health, making it a potential candidate for value investors in the life sciences sector.
Via Chartmill · July 15, 2025
Via The Motley Fool · July 8, 2025
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · April 30, 2025
Via Benzinga · April 29, 2025
Discover ICON PLC, an undervalued stock. NASDAQ:ICLR showcases solid financial health and profitability while maintaining an appealing valuation.
Via Chartmill · April 9, 2025

Elliott Investment Management made several portfolio moves in the fourth quarter, closing multiple options positions and shaking up the activist firm's technology exposure.
Via Benzinga · February 19, 2025

Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN.
Via Benzinga · January 19, 2025

ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00–$15.00, citing biopharma spending cuts and biotech recovery delays.
Via Benzinga · January 14, 2025

Via Benzinga · January 7, 2025

For those who appreciate value investing, ICON PLC (NASDAQ:ICLR) is a compelling option with its solid fundamentals.
Via Chartmill · December 27, 2024

We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty valuations ever.
Via Talk Markets · December 5, 2024

Elliott Investment Management was busy in the third quarter. According to a new 13-F filing with the SEC, the activist made several portfolio moves, with multiple new positions focused around travel and lodging.
Via Benzinga · November 14, 2024